A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease

Biologics are increasingly used to treat Vogt-Koyanagi-Harada disease, but head-to-head comparisons with conventional immunosuppressants are lacking. Here in this randomized trial (Chinese Clinical Trial Registry, ChiCTR2100043061), we assigned 110 patients (27 early-phase and 83 late-phase) to cycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Zhenyu, Dai, Lingyu, Wu, Qiuying, Gao, Yu, Pu, Yanlin, Su, Guannan, Lu, Xiaorong, Zhang, Fuxiang, Tang, Chong, Wang, Yao, Zhou, Chunjiang, Yang, Peizeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290648/
https://www.ncbi.nlm.nih.gov/pubmed/37355662
http://dx.doi.org/10.1038/s41467-023-39483-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290648/
https://www.ncbi.nlm.nih.gov/pubmed/37355662
http://dx.doi.org/10.1038/s41467-023-39483-5

Ejemplares similares